O10.01 PROGNOSTIC AND PREDICTIVE BIOMARKER-BASED SUBGROUPS IN THE NOA-04 TRIAL

BACKGROUND: Molecular biomarkers, including isocitrate dehydrogenase 1 or 2 (IDH1/2) mutation, 1p/19q codeletion, mutations and (consequently) loss of expression of alpha-thalassemia/mental retardation syndrome X-linked (ATRX) and O6-methylguanine-DNA-methyltransferase (MGMT) promoter methylation, i...

詳細記述

保存先:
書誌詳細
主要な著者: Wick, W., Capper, D., Sill, M., Hovestadt, V., Pfister, S.M., Platten, M., Reifenberger, G., von Deimling, A., Weller, M., Wiestler, B.
フォーマット: Artigo
言語:Inglês
出版事項: Oxford University Press 2014
主題:
Oral Presentations
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC4185853/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nou174.82
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料